[Polyunsaturated (essential) fatty acids and their importance in pathogenesis, diagnosis and therapy of multiple sclerosis].
Various aspects concerning the pathogenetic involvement of poly-unsaturated (essential) fatty acids as biochemical co-factors in developing multiple sclerosis (MS) are reported in great detail. Our own studies have also confirmed that differences in the intake or utilization of essential fatty acids do not biochemically induce significant changes in myelin, serum or blood cells. This has long been suspected. The concept of nutritionally or metabolically induced generalized defects in all membranes, especially in the myelin sheath, as a predisposing factor to an increased susceptibility for the development of MS, provoked a gamut of pertinent studies frequently producing controversial results. Hence, these conceptions concerning the pathogenetic involvement of essential fatty acids in MS have been put to rest--even more so after the role of prostaglandins in immunoregulation had become more apparent whose biological precursors are essential fatty acids. Thus, the immunosuppressive effect of high dosage of essential fatty acids under experimental conditions could be explained, disclosing new assessments concerning therapy, new pathogenetic models and further biochemical research.
D001773:Blood Cells / Q000378:metabolism; D001923:Brain Chemistry; D005228:Fatty Acids, Essential / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D008041:Linoleic Acids / Q000097:blood; D009103:Multiple Sclerosis / Q000178:diet therapy / Q000209:etiology / Q000378:metabolism*; D009186:Myelin Sheath / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism
D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D011453:Prostaglandins
Mehrfach-ungesättigte (essentielle) Fettsäuren und ihre Bedeutung in der Pathogenese, Diagnostik und Therapie der multiplen Sklerose.